It is well known that the growth and progression of chronic myeloid leukemia (CML) is attributed to a hybrid protein BCR::ABL1 1,(1) resulting from the t(9;22)(q34;q11) chromosomal translocation. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.